In addition, ADH‐1 treatment in a rat melanoma xenograft model increased tumor delivery of molecules with high binding affinity for plasma proteins (eg, ~70 kDa albumin), including Evans blue dye and the chemotherapeutic agent melphalan.21 This evidence concerns the gene ADH1A and neoplasm.